The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of IBI110 in combination with sintilimab and lenvatinib in first-line of advanced hepatocellular carcinoma: Preliminary results from a phase Ib study.
 
Ming Liu
No Relationships to Disclose
 
Kun Wang
No Relationships to Disclose
 
Quan Bao
No Relationships to Disclose
 
Hongwei Wang
No Relationships to Disclose
 
Kemin Jin
No Relationships to Disclose
 
Wei Liu
No Relationships to Disclose
 
Jia Luo
No Relationships to Disclose
 
Nong Xu
No Relationships to Disclose
 
Tao Zhang
No Relationships to Disclose
 
Yongxiang Xia
No Relationships to Disclose
 
Guoliang Shao
No Relationships to Disclose
 
Baorui Liu
No Relationships to Disclose
 
Jie Shen
No Relationships to Disclose
 
Haonan Chen
Employment - Innovent Biologics
 
Sixiang Long
Employment - Innovent Biologics
 
Yuling Chen
Employment - Innovent Biologics
 
Li Zhao
Employment - Innovent Biologics
 
Hongli Wang
Employment - Innovent Biologics
 
Baocai Xing
No Relationships to Disclose